Heidi Cuthbert

GSK (NYSE:GSK) today announced that China’s National Medical Products Administration (NMPA) has granted approval for Exdensur (depemokimab) as an add-on maintenance treatment for severe asthma characterized by an eosinophilic phenotype.

Leidos (NYSE:LDOS), a Fortune 500 innovation leader in defense, aviation, and information technology, announced today the successful completion of its acquisition of ENTRUST Solutions Group for approximately $2.4 billion.

Goldman Sachs said crypto-linked equities appear selectively attractive after falling 46% from their October 2025 peak, suggesting valuations may be nearing cycle lows.

A newly launched White House mobile app has raised concerns over potential location tracking, data collection and security vulnerabilities following its public release.

Onchain commodity trading volumes are rising sharply, signalling sustained demand for macro exposure on blockchain-based platforms despite ongoing liquidity constraints.

Kraken’s xStocks platform and Fundrise have launched VCXx, a tokenised asset offering onchain exposure to late-stage private technology companies including SpaceX, OpenAI and Anthropic.

Bittensor’s TAO token has surged around 90% in March, driving a broader rally across its ecosystem as subnet tokens collectively reached a market value of about $1.47 billion.

Strategy appears to have paused its bitcoin accumulation last week, breaking a streak of 13 consecutive weekly purchases that added over 90,000 BTC since late December.

Billionaire Bruce Gordon has increased his investment in Nine Entertainment (ASX:NEC) through his private regional broadcaster, WIN Group.

Rocket Pharmaceuticals (NASDAQ:RCKT), a leading biotechnology firm specializing in genetic therapies for rare disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for KRESLADI™ (marnetegragene autotemcel).